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ABSTRACT:
Folic acid is a very important vitamin. It is needed by cells for various physiological
functions. It plays an important role in growth and multiplication of cells and therefore is needed
very much by cancerous cells. One of the ways folate reaches the cells is the folate receptor
mediated endocytosis. Therefore folate binding proteins are abundant on cancerous cells.
Clinical trials proved that the folate receptor targeted drug delivery is very promising to increase
the drug exposure to malignant cells and to reduce the toxicity to healthy cells. It was recently
discovered that folate receptor is also over expressed on activated macrophages which could
contribute to diseases such as crohn’s disease, rheumatoid arthritis, lupus, inflammatory
osteoarthritis, vasculitis, diabetes, ischemia, reperfusion injury, sarcoidosis, glomerulonephritis,
psoriasis and sjogren’s disease.2-5,8 Therefore folate receptor targeted drug delivery would also
be beneficial for above diseases. Folic acid needs a carrier to take it to folate receptor. Serum
Albumin is found to be suitable carrier for folate. In this project we make several conjugates of
Folate-BSA and determine the simple way of making Folate-BSA for commercial use. The
project also focuses on determining the degree of labeling of Folate on BSA. Finally Folate-BSA
is labeled with dyes fluorescein and Rhodamine which can be used in future studies as
fluorescent imaging agents.25-26
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INTRODUCTION:
In this project, we prepare different fluorescein and Rhodamine folate-BSA conjugates.
We discovered a method to prepare folate-BSA for commercial purposes. The conjugates are
used as imaging agents, as a surface for adsorption of gold nanoparticles, to discover effective
folate receptor targeted drug delivery many malignancies (in chemotherapy particularly).
Folic acid:
Folic acid (Fig 1) is a water soluble vitamin B9. Folic acid is the man made form of
Folate which occurs naturally in the body. It is used for various physiological functions. It is very
important for cell growth and maintenance. It also acts as a coenzyme for the synthesis of DNA
and RNA. It also plays important role in the rapid growth and multiplication of cells in the fetus.
Deficiency of folate in pregnant woman will lead to child birth defects. Amino acids histidine,
serine, glycine and methionine require folate for metabolism. Unavailability of folate for
methionine metabolism may lead to excess amounts of homocysteine which may lead to heart
problems. Folate is also required for the proper maintenance of nervous system. In case of folate
deficiency, of all, nucleic acids synthesis is the most affected process which may lead to cancer.13, 11

Folate Receptor:
There are two mechanisms for the transport of folate into cells:
1. Reduced folate carrier (RFC) (Fig-2): This system has high affinity for reduced folate. The

RFC produces an electrochemical potential difference for folates across the cell membranes.
RFC is a transmembrane protein. It comprises of 591 amino acid residues and it uses an
anion exchange mechanism to transport the folates into cells.3-6
6

2. Endocytosis of GPI linked membrane Folate receptor alpha: The Folate receptor internalizes

the bound Folate or Folate conjugated compounds via receptor mediated endocytosis. The
folates are then is retained in the cytoplasm by polyglutamation. This mechanism has high
affinity for oxidized folate, folic acid. Figure 3 explains the transport of folate conjugates. On
the plasma membrane there are small non-clathrin coated invaginations called caveolae
which serve to concentrated folates. The caveolae seal and acidification of the caveolae
results in the dissociation of the folates from MFRα. Folates are then translocated into the
cytoplasm by putative carrier protein.8-12
BSA:

Serum albumin is a protein in plasma. The concentration is around 5g/100ml. It
contributes a total of 80% to the colloid osmotic blood pressure. It is mainly responsible for
maintaining the blood pH. The precursor of the albumin is the preproalbumin synthesized by
liver. From preproalbumin the signal peptide is removed to form proalbumin. The six-residues of
propeptide are removed from the new N-terminus of the proalbumin and the final product is the
albumin. The half-life of albumin is 19 days. In general albumin has tryptophan and methionine.
It has high amounts of cystine, charged amino acids, aspartic and glutamic acids, lysine and
arginine.23-26
Folate conjugates:
Folate can be conjugated with variety of physiologically active compounds. Some of
them are immunotherapeutic agents, protein toxins, chemotherapeutic agents, drug nanoparticles,
liposomes, drug carriers etc. In this report we describe the attachment of folate to BSA. We make
several different concentrations of folate-BSA. Folate BSA can be used as an imaging agent.
7

Imaging agents are chemicals made to detect if a tissue in the body is either benign or
malignant.7
In United States, the second leading cause of death is cancer. Research was done and is
being done to find a way to treat cancer. As a result of this there are many treatments (often not
complete) available today. The most efficient and common one is the chemotherapy. In
chemotherapy the number of cells killed is directly proportional to the amount of drug the cells
are exposed to. But then high doses of the drug exposure are hindered because of the poor
selectivity and the severe toxicity it causes to the normal cells. Therefore research is being
progressed towards the tumor specific treatment.
The ideal solution to achieving tumor specific treatment is to deliver biologically
effective doses of anticancer agents to the tumor tissues with very high specificity. Efforts were
made to develop selective drug by conjugating anti-cancer drugs to harmones, antibodies and
vitamin derivatives. Folic acid which is of low-molecular weight promises as a tumor-homing
agent. Folate also happens to be a high affinity ligand which increases differential specificity of
conjugated anti-cancer drugs by targeting Folate receptor-positive cancer cells.4-6
Research has shown that FR level and density accumulates in the tumor cells (Fig-4) and
therefore it can be hypothesized that Folate conjugated anti-cancer drugs will improve drug
selectivity and decrease the negative side effects on the normal cells. By considering the above it
can be said that undestructive delivery of macromolecules to the living cells is difficult but is
absolutely necessary in cancer treatment. Since the natural endocytosis pathway for vitamin
Folate is known, it can be exploited to deliver the macromolecules if the macromolecules are
first covalently linked to Folate. For example, Folate conjugated ribonuclease, horse radish
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peroxidase, IgG or ferritin. Treatment of cells with above allowed delivery of more than 106
copies of the macromolecules within a 2 hour period.10 Drug coupling to inert carriers may be
designed with the only purpose of prolonging the permeance in blood to get a passive
distribution into some tissues and also conjugating provides a targeting system that selectively
recognizes specific biological structures.
Fluorescein Isothiocyanate and Rhodamine Dye:
Fluoroscein and Rhodamine are fluorescent dyes used to trace the flow of proteins, drugs
or imaging agents in the living cells. Rhodamine is red in color and Fluoroscein orange. They
impart pink and yellow color respectively to Folate-BSA. The absorption maxima of fluorescein
is 494nm and emission maxima is 521nm. For Rhodamine, the absorption maximum is 570nm
and emission maxima at 590nm.
Folate conjugates labeled with FITC or Rhodamine can be used in imaging the cancerous
growth. Targeted delivery of imaging agents can be achieved by use of folate conjugates and the
stage of the disease can be identified. Folate conjugates can be attached to dyes and drugs.
Folate-BSA can also be used as adsorption surface in synthesis of Gold nanoparticles. This
adsorption is explained in figure 4. Gold has high light scattering and absorbing ability. The
detection of cancer would be much easier when gold nanoparticles are made using the folateBSA as the surface for adsorption. Folate conjugates can also to be attached to drugs to provide
targeted drug delivery in case of cancer.3-7
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MATERIALS AND METHODS:
Materials and Reagents:
Albumin from Bovine serum A4503-10G Lot # 029k1394 p code: 1000528230; ≥ 96% (agarose
gel electrophoresis) powder lyophilized 5.0-5.6; 1 % w/v in H2O, Phosphate Buffered saline
without calcium and magnesium Cat No: 21-040-CV Lot No: 21040174 exp 07/11 volume
500ml, Biocinchonic acid solution (10ml) from Sigma Life science B9643-1L, Copper sulfate
(cu2so4)

4%

w/v

prepared

from

copper

(II)

sulfate

pentahydrate,

EDC,

N-((3-

Dimethylaminopropyl)-N-ethyl carbodamide hydrochloride CAS No: 25952-53-8 Mfg by Sigma
Aldrich, Eppendorfs fisher Brand premium 1.5 ml MCT Graduated natural Cat No: 05-408-129
Lot No: 10110134, Beckman VWR Centrifuge filter Modified PES 3k 500µl Low protein
Binding, Epoch plate reader, mini-PROTEANR TGXTM catalog # 456-1096 4-20% 15 well comb
15µl, Precision Plus protein TM catalog # 161-0373 500 µl, Laemmli sample buffer 30ml catalog
# 161-0737 by Bio-Rad laboratories.
Methodology:
Preparation of Protein samples:
The concentrations prepared in step 5 in the flow chart are shown below:
a.

5 fold: 500µl of BSA+PBS, 37µl of FA+EDC and 463µl of PBS

b. 10 fold: 500µl of BSA+PBS, 75µl of FA+EDC and 425 µl of PBS
c. 20 fold: 500µl of BSA+PBS, 150µl of FA+EDC and 350 µl of PBS
d. 40 fold: 500µl of BSA+PBS, 300µl of FA+EDC and 200µl of PBS
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1

2

3

• Preperation of BSA solution: weigh 70mg of BSA and mix it in 7ml of PBS

• Preparation of EDC solution in folic acid of pH 7.4: weigh 90mg of EDC and dissolved in
4.5ml of folic acid and adjust the pH to 7.4 using Hcl and NaOH.

• Preparation of the dilutions: The volume used for different dilutions is as shown below.

• Label 12 different eppendorfs (fig-5)
4
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• Prepare different concentrations 5,10,20,40 fold in eppendorfs.

• Stir all the samples continuously for 4 hrs using a magnetic stirrer (Fig-6).

• Take 500µl of all samples from eppendorfs and transfer into spin filters
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• Centrifuge the sample in spin filters at 8400 RCF for 12 min (Fig-7).
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• Centrifuge for 5 times that is the protein is washed 5 times.

10
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• After 5 washes, resuspend the protein in each spin filter into 500 µl PBS.

• Transfer the above solution into new labeled eppendorfs for further analysis.

• The BSA-Folate is now labeled with Fluoroscein and Rhodamine.

11

Different concentrations of Folate, BSA and EDC are made. EDC is used as a coupling agent
(Fig-8).
Preparation of BSA standards:

BSA standards are prepared according to the thermo scientific instructions as follows:

Vial

A
B
C
D
E
F
G

Diluent
Volume
(μL)
0
125
200
200
200
200
200

BSA Source
and Volume
(μL)
500 of stock
375 of stock
200 of stock
200 of vial B
200 of vial C
200 of vial E
200 of vial F

Concentration
(μg/mL)
2,000
1,500
1,000
750
500
250
125

The standard BSA curve is shown in figure 9.

Folate-BSA labeling with Fluorescein and Rhodamine:

Samples 10 fold and 20 fold are taken and are centrifuged to remove the PBS. To the
washed protein 0.5ml of sodium carbonate is added. The protein in sodium carbonate is taken in
a different tube. To this add 10µl of fluorescein in DMSO (This is prepared by adding 3.25µl of
the dye in 250µl of DMSO). The protein is then washed with DMSO and is resuspended in PBS.
Fluoroscein and Rhodamine are weighed and added to the sample and stirred for four hours
using a magnetic stirrer. After adding the dye, it is allowed to mix overnight. The dye labeled
protein samples are again spin filtered and washed with PBS 5 times. The BCA assay is done on
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the samples. Degree of labeling is calculated. Fluoroscein imparts yellow color and Rhodamine
violet color to the protein BSA samples. (Fig-10)

INSTRUMENTATION:
UV-VIS Plate reading:


In a UV-VIS plate reader, take 100µl of PBS as blank in A1 and A2 wells.



In B1 and B2 wells, take 100µl of the washed pure protein



Read at 280nm and 363nm wavelength at corrected path length.

BCA Analysis:
BSA standards are prepared as per the instructions given in the thermo scientific.
1. BCA standard solution is prepared by mixing 200µl of cu2so4 in 10ml of BCA reagent.
2. 10µl of standards in triplicates and 10µl of samples in duplicates are added in the wells of
the BCA plate. (Fig 11)
3. To all the above wells 200µl of BCA reagent is added.
4. The plate is covered with par film and is incubated for 30 minutes.
5. BCA analysis is run and plate is read at 562nm and the data is recorded.
For those protein samples labeled with Fluoroscein, both uv-vis and BCA readings are
taken but those samples with Rhodamine, only uv-vis is done because the emission
wavelength of Rhodamine is around 562nm which make it overlap with BCA readings taken
at 582nm.
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Gel electrophoresis (fig-12) was done on the protein samples based on Bio Rad. From the
gel we could conclude that there were no impurities (fig-13) since there were no large
aggregates formed. A standard curve of different molecular weights is calculated (fig-14)

RESULTS AND DISCUSSION:
Preparation of Folate-BSA:

Different approaches were tried in preparation of Folate-BSA. EDC was used as a
binding agent. 10µl of EDC is added to 5mg of BSA in an eppendorf and is stirred overnight for
24 hours with a magnetic stirrer and then the centrifugation is done 5 times. But this showed
protein precipitation in the 40 fold and the 60 fold. Even when the stirring time was reduced
from overnight or 24 hrs to 6hrs time, the protein in 40 fold and 60 fold concentrations
precipitated. And when 2hrs time for stirring was used the 60 fold protein concentration still
precipitated. Therefore finally a 4hr stirring time was determined as optimum. The 60 fold still
showed precipitation but was much less relatively. To make the preparation method easy, the
compounds were mixed in different order. First BSA and EDC were weighed in equal quantities
and then folate and PBS were added. This resulted in the formation of crystals in the 40 and 60
fold and the dissolving process was also not that good. After several trials, it was found out that
EDC dissolved well in Folate and BSA dissolved in PBS and both mixed well. Finally to make
the preparation much easier, EDC in folate and BSA in PBS were prepared in bulk and mixed in
quantities as per the calculations and were made up with PBS.
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Degree of labeling of Folate-BSA:
The

Protein

binding

of

Folate-BSA

BCA Reading Molarity

5 Fold 1
5 Fold 2
5 Fold 3
10 Fold 1
10 Fold 2
10 Fold 3
20 Fold 1
20 Fold 2
20 Fold 3
40 Fold 1
40 Fold 2

0.131
0.082
0.337
0.454
0.359
0.404
0.388
0.332
0.34
0.123
0.245

1.97E-06
1.23E-06
5.08E-06
6.84E-06
5.41E-06
6.08E-06
5.84E-06
0.000005
5.12E-06
1.85E-06
3.69E-06

was

calculated

using

the

Molarity x DF Abs at 363nm
1.97E-05
1.23E-05
5.08E-05
6.84E-05
5.41E-05
6.08E-05
5.84E-05
0.00005
5.12E-05
1.85E-05
3.69E-05

0.73
0.64
0.94
1.68
1.63
1.66
3.61
3.11
2.51
3.02
4.41

following

Molarity
6.94E-05
5.21E-05
0.00010993
0.00025265
0.00024301
0.00024879
0.00062488
0.00052845
0.00041273
0.00051109
0.00077917

spreadsheet:

Degree Of Labeling
3.519253278
4.216666275
2.166029033
3.695172877
4.494645203
4.089099363
10.69381344
10.56894889
8.060355097
27.59053241
21.1171157

Moles of folate per mole of BSA= No. of moles of Folate/No. of moles of BSA
In the above calculations, Volume used is 1ml, Dilution factor is 10, Molecular weight of BSA is
66400 and molar extinction coefficient of Folate is 5185. It was calculated as shown in Fig-11
Labeling of Folate-BSA with fluorescein and Rhodamine:
With the molar extinction coefficient of 70,000 M-1cm-1, it was calculated that there were ~ two
fluorescein molecules attached to each BSA. Rhodamine molar extinction coefficient is
85,000M-1cm-1. There was ~ 1 Rhodamine attached to each BSA.

15

CONCLUSION:
A simple way of preparation of different protein concentrations is determined. It is found
out that the 10 and 20 fold concentration is the optimum concentration for Folate BSA.
Concentrations above 40 fold showed precipitation. The degree of Folate labeling on BSA is
determined to be about roughly double for each concentration increased. Fluorescein and
Rhodamine dyes are attached to Folate BSA and it is found that on an average, two fluorescein
molecules and one Rhodamine molecule are attached to each BSA molecule. In future, research
can be focused on preparing Folate BSA for commercial purposes which can in turn be tested for
use with gold nanoparticles, as imaging agents, targeted drug deliver etc.
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Figure-1 Structure of Folic acid

Figure -2: RFC mediated transport of folate into cells. (Medscape)
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Figure 3: Folate receptor mediated endocytosis of folic acid conjugate. Different folate
conjugates bind to the folate receptor with high affinity and are then internalized into endosomes.
(Low, Henne, Accounts of Chemical Research).

Reduced folate carrier in normal cells.

alpha-FR in malignant cells.

Figure-4: Comparison of alpha-FR on normal and malignant cells. (Endocyte Inc.)
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Figure 4: Diagrammatic representation of adsorption of Folate BSA on gold surface.

( Walter

†

A. Henne, Derek D. Doorneweerd, Folate binding detection by enhance quartz balance.)

Figure-5: Labeling of eppendorfs for 5 fold, 10 fold, 20 fold, 40 fold, 60 fold.
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Figure-6 Mixing of all the samples usig a magnetic stirrer.

Figure-7: Beckman Centrifuge used to wash the protein in spin filters.
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Figure-8: schematic representation of EDC coupling.
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BSA standard curve
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Figure -9: BSA standard Curve
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Figure -10: 10 fold and 20 fold Folate-BSA after adding Fluoroscein and Rhodamine.

Figure-11: BCA analysis for blank, BCA standards and protein standards.
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.
Figure-12: Gel electrophoresis of the Folate-BSA protein sample.

Figure 13: Distance migrated by the proteins on a gel
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Figure -14: Calculation of molar extinction coefficient.
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